1Heijl A,Leske MC,Bengtsson B,et al.Reduction of intraocular pressure and glaucoma progression:results from the early manifest glaucoma trial.Arch Ophthalmol,2002,120:1268-1279.
2The AGIS investigators.The relationship between control of intraocular pressure and visual field deterioration:advanced glaucoma intervention study (AGIS).Am J Ophthalmol,2002,130:429-440.
3Spaeth GL.How to value surgical services justly? Ophthalmic Surg Lasers,1999,10:85-90.
5Feiner L,Piltz-Seymour JR.Collaborative initial glaucoma treatment study:a summary of results to date.Curr Opin Ophthalmol,2003,14:106-111.
6The collaborative normal-tension glaucoma intervention study group.The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma.Am J Ophthalmol,1998,126:498-505.
7Michaud JE,Friren B.International brinzolamide adjunctive study group:comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.Am J Ophthalmol,2001,132:235-243.
8Barnebey H,Kwok SY.Patients′ acceptance of a switch from dorzolamide to brinzolamide for the treatment of glaucoma in a clinical practice setting.Clin Ther,2000,22:1204-1212.
9Alm A,Schoenfelder J,McDermott J.A 5-year,multicenter,open-label,safety study of adjunctive latanoprost therapy for glaucoma.Arch Ophthalmol,2004,122:957-965.
10Covert D,Robin AL.Adjunctive glaucoma therapy use associated with travoprost,bimatoprost,and latanoprost.Curr Med Res Opin,2006,22:971-976.
二级参考文献7
1Herkel U, Pfeiffer N. Upda te on topical carbonic anhydrase inhibitors.Curr Opin Ophthalmol, 2001, 12 (2): 88～93. Review
2Cvetkovic RS, Perry CM. Brinzolamide: a review of its use in the management of primary open - angle glaucoma and ocular hypertension. Drugs Aging, 2003, 20 (12): 919～947
3Sall K. The efficacy and safety of brinzolamide 1% ophthalmic suspension (Azopt) as a primary therapy in patients with open - angle glaucoma or ocular hypertension. Brinzolamide Primary Therapy Study Group. SurvOphthalmol, 2000, 44 Suppl2:155～162
4Shin D. Adjunctive therapy with brinzolamide 1% ophthalmic suspension (Azopt) in patients with open - angle glaucoma or ocular hypertension maintained on timolol therapy. Surv Ophthalmol, 2000, 2:163～ 168
5Silver LH. Clinical efficacy and safety of brinzolamide (Azopt), a new topical carbonic anhydrase inhibitor for primary open - angle glaucoma and ocular hypertension. Brinzolamide Primary Therapy Study Group.Am J Ophthalmol, 1998, 126 (3): 400～408
6Barnes GE, Li B, Dean T, et al. Increased optic nerve head blood flow afer 1 week of twice daily topical brinzolamide treatment in Dutch-belted rabbits. SurvOphthalmol, 2000, 2:131～140
